Early neurodevelopment of HIV-exposed uninfected children in the era of antiretroviral therapy: a systematic review and meta-analysis

Catherine J. Wedderburn*, Ella Weldon, Cesc Bertran-Cobo, Andrea M. Rehman, Dan J. Stein, Diana M. Gibb, Shunmay Yeung, Andrew J. Prendergast, Kirsten A. Donald

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Abstract

Background: There are 15·4 million children who are HIV-exposed and uninfected worldwide. Early child development crucially influences later academic and socioeconomic factors. However, the neurodevelopmental outcomes of HIV-exposed uninfected (HEU) children in the era of maternal antiretroviral therapy (ART) remain unclear. We aimed to examine the effects of in-utero exposure to HIV and ART on child neurodevelopment. Methods: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, Africa-Wide Information, PsycInfo, and Global Health databases from inception to May 27, 2020, for studies from the past two decades reporting neurodevelopment of HEU children aged 0–5 years compared with HIV-unexposed (HU) children (aim 1), and effects of different maternal ART regimens on neurodevelopment of HEU children (aim 2). We did narrative syntheses for both aims, and a random-effects meta-analysis of high-quality studies comparing HEU children and HU children, to obtain weighted pooled estimates of effect sizes. This study was registered with PROSPERO, CRD42018075910. Findings: We screened 35 527 records and included 45 articles from 31 studies. Overall, 12 (57%) of 21 studies comparing HEU children and HU children found worse neurodevelopment in HEU children in at least one domain. Study design and methodological quality were variable, with heterogeneity across populations. Meta-analysis included eight high-quality studies comparing 1856 HEU children with 3067 HU children at ages 12–24 months; among HEU children with available data, 1709 (99%) of 1732 were exposed to ART. HEU children had poorer expressive language (effect size –0·17 [95% CI –0·27 to –0·07], p=0·0013) and gross motor function (–0·13 [–0·20 to –0·07], p<0·0001) than HU children, but similar cognitive development (–0·06 [–0·19 to 0·06], p=0·34), receptive language development (–0·10 [–0·23 to 0·03], p=0·14), and fine motor skills (–0·05 [–0·15 to 0·06], p=0·36). Results suggested little or no evidence of an effect of specific maternal ART regimens on neurodevelopment; study heterogeneity prevented meta-analysis. Interpretation: HEU children are at risk of subtle impairments in expressive language and gross motor development by age 2 years. We found no consistent effect of maternal ART regimens analysed, although evidence was scarce. We highlight the need for large high-quality longitudinal studies to assess the neurodevelopmental trajectories of HEU children and to investigate underlying mechanisms to inform intervention strategies. Funding: Wellcome Trust and Medical Research Council.

Original languageEnglish
Pages (from-to)393-408
Number of pages16
JournalThe Lancet Child and Adolescent Health
Volume6
Issue number6
DOIs
StatePublished - Jun 2022
Externally publishedYes

Funding

FundersFunder number
London School of Hygiene and Tropical Medicine
Medical Research Council
Robert Ntozini
Department for International Development, UK Government
Ceri Evans
Barbara Laughton
Wellcome Trust108065, 203525, 203525/Z/16/Z, 108065/Z/15/Z
European CommissionMR/R010161/1

    Fingerprint

    Dive into the research topics of 'Early neurodevelopment of HIV-exposed uninfected children in the era of antiretroviral therapy: a systematic review and meta-analysis'. Together they form a unique fingerprint.

    Cite this